Navigation Links
Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 27, 2009 to Discuss Third Quarter 2009 Results
Date:10/20/2009

WALTHAM, Mass., Oct. 20 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its third quarter 2009 earnings on Tuesday, October 27, 2009. The Company will also host a conference call beginning at 10:00 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company may discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing 706-679-1656 (domestic and international), an access code is not required, or via a link on the Inverness website at www.invmed.com. It is also available via link at https://event.meetingstream.com/r.htm?e=173280&s=1&k=869A5F5A4B771B69A9B01D767DE15ABF. An archive of the call will be available from the same link approximately two hours after the live call has concluded and will be accessible for 90 days.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life at home. Inverness' global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham,
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
2. Inverness - Chemogen Establish Exclusive License for TB Antibodies
3. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
4. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
7. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
10. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
11. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...OCKHOLM, November 20 Karolinska De...estment Fund (EIF) has entered into a,co-investmen...nd will be,managed by Karolinska Development and u...stage pharmaceutical and medical technology compan...co-investment fund. The agreement,represents EIF,s...
(Date:11/19/2009)... Nov. 19 Danish Prince Joachim ina...hanol plant in Kalundborg, Denmark, on Wednesday, ...rst and largest 2nd generation ethanol demonstrati...re used in the plant,s innovative process for conv...sco, was the first to market with commercial enzym...
(Date:11/19/2009)...Md., Nov. 19 Spherix Inc...hnology for diabetes therapy, and a provider of te..., supplement, biotechnology and pharmaceutical com...nnual Meeting of Shareholders. ,, At the meetin...SPEX ) elected the following members to the Board ...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies Form Int...rdinate Best Practices in Risk Reduction ,Five M...Gene Synthesis Capacity , ...quo;s leading gene synthesis companies today annou...ning protocol to promote biosecurity in the gene s...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
... Anesiva,Inc. (Nasdaq: ANSV ) today announced tha... senior vice president and chief medical officer. ...latory functions., "Bill brings to Anesiva deep c...ain management products, and a medical background ...ey role as we proceed with,the clinical developmen...
...wire-FirstCall/ -- China Sky One,Medical, Inc. ("C...Y ), a,leading fully integrated pharmaceutical com... in the People,s Republic of China ("PRC"), today,...s common stock on the,NASDAQ Global Market., Chin...lobal Market on,September 15, 2008, and that the l...
...ph F. Finn, Jr.,C.P.A. ("Finn"), Assignee of the a...it of creditors, announced today that all pharmace...led bid auction on October 10,2008., With SRx-503...first and,second line treatment for Parkinson,s di...pprox. $600 million US only), despite a severe sid...
Other Biology Technology:Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer 2China Sky One Medical, Inc. Approved to List on the NASDAQ Global Market 2China Sky One Medical, Inc. Approved to List on the NASDAQ Global Market 3Spherics, Inc. Offers Once Daily Extended Release Formulation for Sustained and Stable Pramipexole Delivery 2
(Date:11/22/2009)...arine Life scientists have inventoried an astonish...sea species that have never known sunlight - creat...k world down to 5,000 meters (~3 miles) below the ... sonar and other vanguard technologies, animals kn...mber 17,650, a diverse collection of species rangi...
(Date:11/21/2009)...rmany, November 20,2009 / b3c newswire / - KINAX...f a financing round, gaining two new investors in ...e time KINAXO reports that Jrgen Schumacher has be...y board. , KINAXO shareholders Axel Ullrich, Hel...nys institutional investors Mountain Partners, Bio...
(Date:11/20/2009)... a group of University of Oklahoma researchers wer... the human genome project. Today, the OU Advance...an international effort to sequence the tomato gen...nal Science Foundation for plant genomics. , "T...o improving the tomato and crop yields will improv...
Breaking Biology News(10 mins):Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Exercise helps patients with non alcoholic fatty liver disease 50560 1Exercise helps patients with non alcoholic fatty liver disease 50560 2Study examines liver transplantation after drug induced acute liver failure 50558 1Study examines liver transplantation after drug induced acute liver failure 50558 2Study examines liver transplantation after drug induced acute liver failure 50558 3Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 1Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 3
...ntly opened pulp mill in Chile has devastated one ...wetlands, decimating its famed population of black...WWF-led team of investigators said Monday. , "What...ed swans in South America has been wiped out in le...," said Clifton Curtis, director of World Wildlife...
...ells are unique among human cells in that they pos... any other cell of the body, offering a hypothetic... broken spinal cords, or correcting genetic diseas...rived from very early embryos show the most promis... in the process of acquiring the cells themselves....
...n,s University study of fruit flies that may revol...ntified the genes affected by a widely-prescribed ... (MTX), a popular cancer-fighting drug also used t... arthritis, and lupus, lasts a long time in the bo... who have it in their systems. The study of the dr...
Other Biology News:Pulp mill devastates swans' sanctuary in Chile 2Center releases new public survey on stem cells 2Center releases new public survey on stem cells 3Fruit fly research set to revolutionize study of birth defects 2
UNOsphere S Support, 100 ml from Bio-Rad
S-Protein Agarose from Novagen
...a (Aph-1aL,S Loop 92-115), O2F1 Affinity Purified ...plex consisting of presenilin, nicastrin, Aph-1 an...proteolytic activity. The gamma secretase complex ...e proteins including Amyloid precursor protein, No...
... Epitope: A BALB/c mouse was immunized with Gluta...ecommended Storage: Store vial at -20 C prior to ...below for extended storage. Avoid cycles of freez...tely clear after standing at room temperature. ...
Biology Products: